- Home
- ABOS vs SBXC Comparison
ABOS vs SBXC Comparison
Compare ABOS & SBXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- SBXC
- Stock Information
- Founded
- ABOS 1996
- SBXC 2021
- Country
- ABOS United States
- SBXC United States
- Employees
- ABOS N/A
- SBXC N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- SBXC Blank Checks
- Sector
- ABOS Health Care
- SBXC Finance
- Exchange
- ABOS Nasdaq
- SBXC Nasdaq
- Market Cap
- ABOS 166.4M
- SBXC 114.6M
- IPO Year
- ABOS 2021
- SBXC 2023
- Fundamental
- Price
- ABOS $2.22
- SBXC $10.76
- Analyst Decision
- ABOS Strong Buy
- SBXC
- Analyst Count
- ABOS 4
- SBXC 0
- Target Price
- ABOS $9.00
- SBXC N/A
- AVG Volume (30 Days)
- ABOS 185.7K
- SBXC 152.7K
- Earning Date
- ABOS 08-13-2024
- SBXC 01-01-0001
- Dividend Yield
- ABOS N/A
- SBXC N/A
- EPS Growth
- ABOS N/A
- SBXC 89.85
- EPS
- ABOS N/A
- SBXC 0.27
- Revenue
- ABOS N/A
- SBXC N/A
- Revenue This Year
- ABOS N/A
- SBXC N/A
- Revenue Next Year
- ABOS N/A
- SBXC N/A
- P/E Ratio
- ABOS N/A
- SBXC $39.98
- Revenue Growth
- ABOS N/A
- SBXC N/A
- 52 Week Low
- ABOS $1.81
- SBXC $10.19
- 52 Week High
- ABOS $5.76
- SBXC $11.32
- Technical
- Relative Strength Index (RSI)
- ABOS 32.70
- SBXC 73.79
- Support Level
- ABOS $2.73
- SBXC $10.68
- Resistance Level
- ABOS $2.92
- SBXC $10.69
- Average True Range (ATR)
- ABOS 0.19
- SBXC 0.02
- MACD
- ABOS -0.06
- SBXC 0.01
- Stochastic Oscillator
- ABOS 7.17
- SBXC 100.00
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About SBXC SilverBox Corp III
SilverBox Corp III is a newly incorporated blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.